OTC Markets OTCPK - Delayed Quote • USD
Eastwood Bio-Medical Canada Inc. (EWOOF)
At close: November 7 at 11:56 AM EST
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
10/31/2019
Total Revenue
736.7510
867.9360
1,299.7630
981.0510
718.3360
--
Cost of Revenue
294.6920
319.5710
397.0190
522.6810
538.7640
--
Gross Profit
442.0570
548.3650
902.7440
458.3700
179.5720
--
Operating Expense
944.9270
1,053.5670
1,032.0890
1,054.2200
1,031.4120
--
Operating Income
-502.8700
-505.2020
-129.3450
-595.8500
-851.8400
--
Net Non Operating Interest Income Expense
-24.9490
-28.1640
-10.7050
-2.7880
-1.0050
--
Other Income Expense
-3.7840
-13.2320
-9.8290
-4.9550
0.4120
--
Pretax Income
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
--
Net Income Common Stockholders
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
--
Diluted NI Available to Com Stockholders
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
--
Basic EPS
-0.01
-0.01
-0.00
-0.01
-0.01
--
Diluted EPS
-0.01
-0.01
-0.00
-0.01
-0.01
--
Basic Average Shares
68,885.9690
68,885.9690
68,885.9690
68,885.9690
68,885.9690
--
Diluted Average Shares
68,885.9690
68,885.9690
68,885.9690
68,885.9690
68,885.9690
--
Rent Expense Supplemental
--
--
--
--
--
61.1010
Total Expenses
1,239.6190
1,373.1380
1,429.1080
1,576.9010
1,570.1760
--
Net Income from Continuing & Discontinued Operation
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
--
Normalized Income
-527.8190
-533.3660
-139.4650
-598.6380
-852.4330
--
Interest Income
--
--
--
--
1.3690
16.4120
Interest Expense
10.7050
28.1640
10.7050
2.7880
--
--
Net Interest Income
-24.9490
-28.1640
-10.7050
-2.7880
-1.0050
--
EBIT
-516.1020
-518.4340
-139.1740
-600.8050
-851.8400
--
EBITDA
-408.5780
-410.5820
-32.3230
-495.5040
-746.0960
--
Reconciled Cost of Revenue
294.6920
319.5710
397.0190
522.6810
538.7640
--
Reconciled Depreciation
107.5240
107.8520
106.8510
105.3010
105.7440
--
Net Income from Continuing Operation Net Minority Interest
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
--
Total Unusual Items Excluding Goodwill
-3.7840
-13.2320
-10.4140
-4.9550
--
--
Total Unusual Items
-3.7840
-13.2320
-10.4140
-4.9550
--
--
Normalized EBITDA
-404.7940
-397.3500
-21.9090
-490.5490
-746.0960
--
10/31/2019 - 8/2/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade